bullish
Venus Medtech (启明医疗) IPO: Technical Comparison of VenusA-Valve and Peers
657 Views11 Sep 2019 11:26
Venus Medtech, a China Hangzhou-based transcatheter heart valve medical device player, is looking to raise up to USD 300 million via a listing in...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
- Venus Medtech (启明医疗) IPO Trading: Allocation and Buy-Level09 Dec 2019
- Venus Medtech (启明医疗) IPO: Valuation Still OK at the High End26 Nov 2019
- Venus Medtech (启明医疗) Pre-IPO: Thoughts on Valuation11 Nov 2019
- Venus Medtech (启明医疗) IPO: Technical Comparison of VenusA-Valve and Peers11 Sep 2019
- Venus Medtech (启明医疗) IPO: Has the Elements for a Hot Healthcare Deal21 Aug 2019
x